BDNF and depressive symptom measurement: For example, it has been shown that fluoxetine-induced upregulation of the Brain-Derived Neurotrophic Factor (BDNF), involved in depression pathophysiology [49], may be mediated by both P1 and P2 receptor signaling [50].